Astrana Health, Inc.
No enriched coverage for $ASTH in the last 7 days.
No SEC Form 4 filings for $ASTH in the last 30 days.
See all $ASTH insider activity →Alignment Healthcare (ALHC) announced its Medicare Advantage plan will expand to three new California counties in 2027, adding Hoag and Astrana Health to its provider network, totaling 25 counties served.
Astrana Health notified the SEC of a data breach caused by a social engineering attack, potentially exposing patient, provider, and corporate data. The company is investigating and has taken remedial actions. Astrana, with 2025 revenue of $3.2B, stated the incident is material but does not expect it to affect its financial condition or operations. The company has cyber insurance but cannot guarantee it will cover all losses.
Astrana Health (ASTH) shares fell 5.5% after disclosing a cybersecurity incident and data breach at its subsidiary, adding to existing pressures from a securities-law investigation and Medicare regulatory concerns. The stock is volatile, down 33.3% from its 52-week high, and up 31.7% year-to-date. Investors are assessing the long-term impact of potential Medicare Advantage reforms on the company's margins.
Recent ASTH coverage spans market movers, regulation and insider activity.
Alignment Healthcare (ALHC) announced its Medicare Advantage plan will expand to three new California counties in 2027, adding Hoag and Astrana Health to its provider network, totaling 25 counties served.
Astrana Health notified the SEC of a data breach caused by a social engineering attack, potentially exposing patient, provider, and corporate data. The company is investigating and has taken remedial actions. Astrana, with 2025 revenue of $3.2B, stated the incident is material but does not expect it to affect its financial condition or operations. The company has cyber insurance but cannot guarantee it will cover all losses.
The breach raises operational risk and could pressure margins, likely keeping the stock under pressure.
Short‑term sell pressure expected as investors assess breach impact.
Negative short‑report catalyst likely to pressure the stock further.
AlphAI scores every news story that mentions ASTH with an AI model for sentiment and relevance, and aggregates insider trades from Astrana Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Alignment Healthcare (ALHC) announced its Medicare Advantage plan will expand to three new California counties in 2027, adding Hoag and Astrana Health to its provider network, totaling 25 counties served.
1 min readAstrana Health notified the SEC of a data breach caused by a social engineering attack, potentially exposing patient, provider, and corporate data. The company is investigating and has taken remedial actions. Astrana, with 2025 revenue of $3.2B, stated the incident is material but does not expect it to affect its financial condition or operations. The company has cyber insurance but cannot guarantee it will cover all losses.
2 min readAstrana Health (ASTH) shares fell 5.5% after disclosing a cybersecurity incident and data breach at its subsidiary, adding to existing pressures from a securities-law investigation and Medicare regulatory concerns. The stock is volatile, down 33.3% from its 52-week high, and up 31.7% year-to-date. Investors are assessing the long-term impact of potential Medicare Advantage reforms on the company's margins.
2 min readAstrana Health ASTH fell 7% premarket after reporting a 'material' cybersecurity incident at its subsidiary, Astrana Health Management. The breach involved unauthorized access to private/confidential data via social engineering. The company is investigating and stated the incident won't materially impact its financials, as of Sept. 22.
1 min readAstrana Health (ASTH) shares dropped 6% after Glass House Research criticized its accounting, questioning profit sustainability and organic growth. The report highlighted concerns over acquisition-related marks, related-party loans, and Medicare exposure. ASTH's 2025 revenue fell 3.5%, and net income was $1.2 million. The firm also noted rising claims expenses and negative capital allocation.
2 min readSeveral healthcare stocks fell after bipartisan lawmakers introduced the Protecting Approved Care Act, which aims to reform Medicare Advantage plans. The bill could increase medical loss ratios and administrative burdens for insurers. Astrana Health (ASTH) fell 2.7%, Clover Health (CLOV) 4.8%, Alignment Healthcare (ALHC) 12.6%, and Novavax (NVAX) 3.6%.
2 min readKitayama Mitchell W sold (to issuer) 8,500 shares of Astrana Health, Inc. (ASTH) at $37.09 ($0.32M total) on 2026-08-31.
1 min readEvolent Health (EVH) reported Q2 revenue of $652.5M, up 46.9% YoY, beating estimates. Astrana Health (ASTH) reported $972.5M, up 48.5%, missing estimates. Tandem Diabetes (TNDM) reported $254.6M, up 5.8%, in line with estimates. GoodRx (GDRX) reported $200.4M, down 1.3%, beating estimates. All stocks rose post-earnings.
3 min readSchmidt David sold (to issuer) 20,000 shares of Astrana Health, Inc. (ASTH) at $38.59 ($0.77M total) on 2026-08-14.
1 min readAstrana Health (ASTH) reported Q2 2026 revenue of $972.5M, up 49% YoY, and adjusted EBITDA of $68.9M, up 43%. Adjusted EPS was $0.80. Six-month free cash flow was $92.9M. The company reaffirmed full-year revenue guidance of $3.8B to $4.1B and raised adjusted EBITDA guidance to $255M to $280M. Net leverage was 2.26.
7 min read
